002020 京新藥業
按盤價 
11.730 -0.950 (-7.492%)
11.730 -0.950 (-7.492%) | 2026/06 - 中期 | 2025/12 | 2024/12 | 2023/12 | 2022/12 | 盈利能力分析 |
| 淨資產收益率 ROE (%) | 5.943 | 12.844 | 12.401 | 11.613 | 13.235 |
| 總資產報酬率 ROA (%) | 4.374 | 9.131 | 8.648 | 8.064 | 9.522 |
| 投入資產回報率 ROIC (%) | 5.425 | 11.557 | 10.975 | 10.130 | 11.708 | 邊際利潤分析 |
| 銷售毛利率 (%) | 50.502 | 50.149 | 49.974 | 50.573 | 53.275 |
| 營業利潤率 (%) | 21.163 | 21.199 | 20.286 | 17.857 | 20.017 |
| 息稅前利潤/營業總收入 (%) | 20.736 | 20.130 | 18.746 | 16.360 | 17.937 |
| 淨利潤/營業總收入 (%) | 17.912 | 18.840 | 17.293 | 15.590 | 17.668 | 收益指標分析 |
| 經營活動淨收益/利潤總額(%) | 105.815 | 97.291 | 93.439 | 89.232 | 92.627 |
| 價值變動淨收益/利潤總額(%) | -0.950 | 3.075 | -3.959 | 6.103 | 5.780 |
| 營業外收支淨額/利潤總額(%) | -1.941 | 0.193 | 0.044 | -0.850 | -0.840 | 償債能力分析 |
| 流動比率 (X) | 2.482 | 1.731 | 1.361 | 1.616 | 1.807 |
| 速動比率 (X) | 1.972 | 1.329 | 0.989 | 1.302 | 1.381 |
| 資產負債率 (%) | 24.071 | 27.737 | 29.221 | 30.631 | 29.753 |
| 帶息債務/全部投入資本 (%) | 2.817 | 3.942 | 5.566 | 6.452 | 6.879 |
| 股東權益/帶息債務 (%) | 3,262.139 | 2,300.406 | 1,604.489 | 1,358.410 | 1,261.677 |
| 股東權益/負債合計 (%) | 313.447 | 258.871 | 240.923 | 225.326 | 234.920 |
| 利息保障倍數 (X) | -874.189 | -18.139 | -12.098 | -12.154 | -9.375 | 營運能力分析 |
| 應收賬款周轉天數 (天) | 68.545 | 67.811 | 57.105 | 47.079 | 44.518 |
| 存貨周轉天數 (天) | 143.262 | 138.318 | 125.062 | 129.902 | 147.920 |
| 備註： | 報價延遲最少15分鐘，資料更新時間為 07/09/2026 12:25 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
